Align Technology, Inc. (NASDAQ:ALGN – Free Report) – Equities research analysts at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for shares of Align Technology in a research note issued to investors on Monday, July 14th. Leerink Partnrs analyst M. Cherny now anticipates that the medical equipment provider will post earnings of $2.10 per share for the quarter, up from their previous forecast of $2.07. The consensus estimate for Align Technology’s current full-year earnings is $7.98 per share. Leerink Partnrs also issued estimates for Align Technology’s Q3 2025 earnings at $2.28 EPS, Q4 2025 earnings at $2.40 EPS, FY2025 earnings at $8.43 EPS, FY2026 earnings at $9.33 EPS, FY2027 earnings at $10.67 EPS and FY2028 earnings at $11.85 EPS.
A number of other research firms also recently weighed in on ALGN. Piper Sandler restated an “overweight” rating and set a $250.00 price target (up previously from $235.00) on shares of Align Technology in a report on Thursday, May 1st. Mizuho reduced their target price on Align Technology from $250.00 to $245.00 and set an “outperform” rating for the company in a report on Tuesday, April 29th. Wells Fargo & Company dropped their price target on shares of Align Technology from $255.00 to $246.00 and set an “overweight” rating on the stock in a research report on Thursday, May 1st. Hsbc Global Res lowered shares of Align Technology from a “strong-buy” rating to a “hold” rating in a research report on Friday, April 25th. Finally, Evercore ISI raised their price target on Align Technology from $200.00 to $220.00 and gave the company an “outperform” rating in a research report on Wednesday, July 9th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $242.92.
Align Technology Trading Up 1.1%
ALGN opened at $192.27 on Thursday. The stock has a fifty day moving average price of $185.82 and a 200 day moving average price of $187.46. Align Technology has a 1 year low of $141.74 and a 1 year high of $263.24. The stock has a market cap of $13.94 billion, a price-to-earnings ratio of 35.02, a PEG ratio of 2.01 and a beta of 1.63.
Align Technology (NASDAQ:ALGN – Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The medical equipment provider reported $2.13 earnings per share for the quarter, beating analysts’ consensus estimates of $2.00 by $0.13. The business had revenue of $979.26 million for the quarter, compared to the consensus estimate of $977.90 million. Align Technology had a return on equity of 13.52% and a net margin of 10.29%. Align Technology’s revenue for the quarter was down 1.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.14 earnings per share.
Institutional Investors Weigh In On Align Technology
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in Align Technology by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,441,592 shares of the medical equipment provider’s stock worth $1,341,031,000 after purchasing an additional 185,187 shares during the last quarter. Ninety One UK Ltd increased its stake in shares of Align Technology by 58.7% in the 1st quarter. Ninety One UK Ltd now owns 1,937,555 shares of the medical equipment provider’s stock valued at $307,800,000 after acquiring an additional 716,954 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Align Technology by 2.2% during the fourth quarter. Geode Capital Management LLC now owns 1,790,014 shares of the medical equipment provider’s stock worth $372,299,000 after acquiring an additional 39,209 shares in the last quarter. Invesco Ltd. lifted its stake in Align Technology by 12.7% in the first quarter. Invesco Ltd. now owns 1,219,715 shares of the medical equipment provider’s stock valued at $193,764,000 after buying an additional 137,553 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Align Technology in the 4th quarter valued at about $190,792,000. Institutional investors and hedge funds own 88.43% of the company’s stock.
Align Technology announced that its Board of Directors has approved a share repurchase plan on Tuesday, May 6th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the medical equipment provider to buy up to 7.9% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.
About Align Technology
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Read More
- Five stocks we like better than Align Technology
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- The Market Rally Is Gaining Momentum—Don’t Get Left Behind
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- High-Flying GE Aerospace Drops After Blowout Q2 — What Now?
- What is a Stock Market Index and How Do You Use Them?
- Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.